Similar articles

• Comparison between squamous cell carcinoma-associated antigen and CA-125 in patients with carcinoma of the cervix.

  Lehtovirta P, Viinikka L, Ylikorkala O. Lehtovirta P, et al. Gynecol Oncol. 1990 May;37(2):276-8. doi: 10.1016/0090-8258(90)90347-n. Gynecol Oncol. 1990. PMID: 2344974
• Adenocarcinoma of the uterine cervix. Prognostic significance of pretreatment serum CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen levels in relation to clinical and histopathologic tumor characteristics.

  Duk JM, De Bruijn HW, Groenier KH, Fleuren GJ, Aalders JG. Duk JM, et al. Cancer. 1990 Apr 15;65(8):1830-7. doi: 10.1002/1097-0142(19900415)65:8<1830::aid-cncr2820650828>3.0.co;2-s. Cancer. 1990. PMID: 2317761
• A comparison of pretreatment serum levels of four tumor markers in patients with endometrial and cervical carcinoma.

  Gadducci A, Ferdeghini M, Prontera C, Giordano P, Cristofani R, Bianchi R, Fioretti P. Gadducci A, et al. Eur J Gynaecol Oncol. 1990;11(4):283-8. Eur J Gynaecol Oncol. 1990. PMID: 2245812
• The use of tumor markers in the management of patients with gynecologic carcinomas.

  Berchuck A, Boente MP, Bast RC Jr. Berchuck A, et al. Clin Obstet Gynecol. 1992 Mar;35(1):45-54. doi: 10.1097/00003081-199203000-00009. Clin Obstet Gynecol. 1992. PMID: 1544249 Review. No abstract available.
• Factors regulating SCC antigen expression in squamous cell carcinoma of the uterine cervix.

  Maruo T, Yoshida S, Samoto T, Tateiwa Y, Peng X, Takeuchi S, Motoyama S. Maruo T, et al. Tumour Biol. 1998;19(6):494-504. doi: 10.1159/000030043. Tumour Biol. 1998. PMID: 9817979 Review.